Log In
Print
BCIQ
Print
Print this Print this
 

Zorvolex (Lower dose submicron diclofenac)

Also known as: IP 880

  Manage Alerts
Collapse Summary General Information
Company Iroko Pharmaceuticals LLC
DescriptionLower dose submicron formulation of the NSAID diclofenac using SoluMatrix fine particle technology
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat mild to moderate acute pain in adults; Treat moderate to severe pain; Treat osteoarthritis (OA) pain; Treat osteoarthritis pain in adults; Treat post-surgical acute pain
Regulatory Designation

U.S. - Undisclosed Review (Treat mild to moderate acute pain in adults)

Partner

Algorithm S.A.L.; Calox de Costa Rica S.A.; EMS S.A.; iCeutica Inc.; PT Pratapa Nirmala-Fahrenheit


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today